Unlock instant, AI-driven research and patent intelligence for your innovation.

Anthraquinone compounds and applications thereof

A compound, anthraquinone technology, applied in the field of simulating BH3-only proteins, can solve the problems of insufficient BH3 similarity, large toxic side effects, and toxic side effects

Inactive Publication Date: 2012-10-17
DALIAN UNIV OF TECH
View PDF1 Cites 8 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

But they all have shortcomings: Gossypol and Obatoclax have insufficient BH3 similarity, and are not absolute BH3 analogs. In other words, due to the existence of other targets, they have cytotoxicity independent of BAX / BAK, indicating that there are other effects target and therefore have toxic side effects
However, these compounds are all cytotoxic drugs, have no targeting to tumor cells, and have great toxic and side effects

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Anthraquinone compounds and applications thereof
  • Anthraquinone compounds and applications thereof
  • Anthraquinone compounds and applications thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0046] Example 1: Preparation of 6-bromo-2,3-dihydroxyanthraquinone-9,10-dione

[0047]

[0048] Take 4.44g (0.03mol) of phthalic anhydride, add 20ml of water, 2.4g (0.06mol) of NaOH, stir at room temperature until completely dissolved. After cooling, add 3ml of liquid bromine dropwise, and react at 90°C. If there is solid precipitation in the middle, add an appropriate amount of water. After 6 hours of reaction of the clear solution, the color changed from dark red to light, and solids precipitated out after cooling overnight. Filter the solid, discard the filtrate, dissolve the solid in 20ml of hot water, add HCl to neutralize to pH<4, and extract with ethyl acetate. After extraction three times, the organic layer was dried over anhydrous magnesium sulfate for 2 hours, filtered, and the filtrate was spin-dried to obtain 1.86 g of 4-bromo-phthalic acid as a white solid with a yield of 66.9% and a melting point of 164°C.

[0049] Weigh 0.735 g of dry 4-bromo-phthalic acid...

Embodiment 2

[0052] Example 2: Preparation of 6-bromo-1,2,3-trihydroxyanthraquinone-9,10-dione

[0053] Take 4.44g (0.03mol) of phthalic anhydride, add 20ml of water, 2.4g (0.06mol) of NaOH, stir at room temperature until completely dissolved. After cooling, add 3ml of liquid bromine dropwise, and react at 90°C. If there is solid precipitation in the middle, add an appropriate amount of water. After 6 hours of reaction of the clear solution, the color changed from dark red to light, and solids precipitated out after cooling overnight. Filter the solid, discard the filtrate, dissolve the solid in 20ml of hot water, add HCl to neutralize to pH<4, and extract with ethyl acetate. After extraction three times, the organic layer was dried over anhydrous magnesium sulfate for 2 hours, filtered, and the filtrate was spin-dried to obtain 1.86 g of 4-bromo-phthalic acid as a white solid with a yield of 66.9% and a melting point of 164°C.

[0054]

[0055] Weigh 0.735 g of dry 4-bromo-phthalic a...

Embodiment 3

[0058] Example 3: Preparation of 6-phenylthio-2,3-dihydroxyanthraquinone-9,10-dione

[0059]

[0060] Take 0.16g (0.5mmol) 6-bromo-2,3-dihydroxyanthraquinone-9,10-dione, 0.33g (3mmol, 310uL) thiophenol, 10mgCuI, add to 10mL DMF, N 2 Under protection, heat and stir at 140°C for 6h. After cooling, add 50 mL of 10% HCl solution by mass fraction, let stand for 1 hour, and filter. The solid was dried, dissolved in ethyl acetate, filtered, the filtrate was dried, and the solvent was evaporated to obtain a khaki crude product. Dry loading, ethyl acetate:petroleum ether=1:1 (1% acetic acid) was used as the eluent, and silica gel column separation gave 0.043 g of a yellow solid with a yield of 24.7%.

[0061] Structural characterization: M.p.251°C (sublimation). 1 H NMR(400M,DMSO):δ10.63(d,J=12Hz,2H),8.02(d,J=8.0Hz,1H),7.63(d,1H),7.52(m,J=12Hz,5H) ,7.45(s,1H), 7.37(d,J=8Hz,2H),TOF MS(EI + ):C 20 h 12 o 4 S, (m / z): calcd for 348.37, found 348.05.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a class of anthraquinone compounds and applications thereof. The compounds have a structure represented by a general formula I, wherein R1 is selected from Br and XPH-(o, m, p)R3, X is O or S, R3 is selected from H, halogen, a saturated or unsaturated alkyl group containing carbon atoms of 1-6, an alkoxy group containing carbon atoms of 1-4, an amino group, and a phenyl group, and R2 is H or OH. The anthraquinone compounds of the present invention can be adopted as an analog of BH3-only protein, and can be competitively combined with proteins of Bcl-2, Bcl-XL and Mcl-1 or antagonize proteins of Bcl-2, Bcl-XL and Mcl-1, such that apoptosis is specifically induced while cell killing effects are not provided for normal cells and tumor cells missing Bax and Bak. The anthraquinone compounds of the present invention are expected to be developed into Bcl-2 family protein-targeting safe and efficient protein inhibitor drugs.

Description

technical field [0001] The present invention relates to a new class of anthraquinone Bcl-2 family protein inhibitors and their in vivo and in vitro analog BH3-only proteins, which can competitively bind and antagonize Bcl-2 and Mcl-1 proteins, thereby inducing cell apoptosis and applications as anticancer compounds. Background technique [0002] Molecularly targeted antineoplastic drugs are becoming a hot spot in new drug development and a new generation of market-oriented products after cytotoxic antineoplastic drugs. Bcl-2 family proteins are one of the most important molecular targets for antagonizing and reversing the immortality of malignant tumors. Therefore, the drugs that specifically antagonize the Bcl-2 protein will finally achieve the goal of anti-cancer with high efficiency and no toxic side effects by specifically inducing tumor cell apoptosis. Among the Bcl-2 inhibitors, highly specific BH3 analogs (BH3 mimetics) have the most significant anti-tumor effect, t...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07C50/34C07C46/00C07C323/22C07C319/14A61K31/122A61P35/00
Inventor 张志超李祥乾
Owner DALIAN UNIV OF TECH